<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Bone and soft tissue sarcomas, tumors of the skin</journal-id><journal-title-group><journal-title xml:lang="en">Bone and soft tissue sarcomas, tumors of the skin</journal-title><trans-title-group xml:lang="ru"><trans-title>Саркомы костей, мягких тканей и опухоли кожи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2219-4614</issn><issn publication-format="electronic">2782-3687</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">452</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SOFT TISSUE SARCOMAS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>САРКОМЫ МЯГКИХ ТКАНЕЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Ultrasound diagnostics of utrerus leiomyosarcoma metastases</article-title><trans-title-group xml:lang="ru"><trans-title>Ультразвуковая диагностика метастазов лейомиосаркомы матки</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mnatsakanyan</surname><given-names>I. K.</given-names></name><name xml:lang="ru"><surname>Мнацаканян</surname><given-names>И. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>г. Москва</p></bio><email>mnatsakanyanik@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chekalova</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Чекалова</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>г. Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lasareva</surname><given-names>N. I.</given-names></name><name xml:lang="ru"><surname>Лазарева</surname><given-names>Н. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>г. Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fedenko</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Феденко</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>г. Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">FGBU N.N. Blokhin Russian Cancer Research Center</institution></aff><aff><institution xml:lang="ru">ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-11-25" publication-format="electronic"><day>25</day><month>11</month><year>2014</year></pub-date><volume>6</volume><issue>3-4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>37</fpage><lpage>43</lpage><history><date date-type="received" iso-8601-date="2022-01-24"><day>24</day><month>01</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-01-24"><day>24</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2014, Mnatsakanyan I.K., Chekalova M.A., Lasareva N.I., Fedenko A.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2014, Мнацаканян И.К., Чекалова М.А., Лазарева Н.И., Феденко А.А.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="en">Mnatsakanyan I.K., Chekalova M.A., Lasareva N.I., Fedenko A.A.</copyright-holder><copyright-holder xml:lang="ru">Мнацаканян И.К., Чекалова М.А., Лазарева Н.И., Феденко А.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://sarbon.abvpress.ru/jour/article/view/452">https://sarbon.abvpress.ru/jour/article/view/452</self-uri><abstract xml:lang="en"><p>Material of the research were the results of the survey of 37 patients with uterus leiomyosarcoma (LMS), who were treated and observed at federal state scientific institution «Russian Cancer Research Center them. Blokhin» in the period from 2012 to 2014. Sonographic signs of metastases and recurrent uterus LMS are mostly hypoechogenic – the same as the signs of primary tumor. Echographic diagnostics makes possible to detect the presence of a pathological process, its localization, structure and sizes of tumor, clarify the diagnosis.</p></abstract><trans-abstract xml:lang="ru"><p>Материалом исследования явились результаты обследования 37 больных лейомиосаркомой (ЛМС) тела матки, которые лечились и наблюдались в РОНЦ РАМН за период с 2012 по 2014 г. Ультразвуковая картина метастазов и рецидивов ЛМС тела матки характеризовалась такими же признаками, как и первичная опухоль, – преобладали отражения пониженной интенсивности. Проведение эхографии позволяет выявить патологический очаг, определить локализацию, размеры и структуру опухоли, состояние окружающих органов и тканей, регионарных лимфатических узлов, а также дать оценку распространенности заболевания, уточнить диагноз и получить полноценное представление о местно-регионарном и отдаленном распространении ЛМС матки.</p></trans-abstract><kwd-group xml:lang="en"><kwd>leiomyosarcoma uteri</kwd><kwd>ultrasound</kwd><kwd>metastases</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лейомиосаркома тела матки</kwd><kwd>ультразвуковая диагностика</kwd><kwd>метастазы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. D. Angelo E., Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010, v. 74, p. 131-139.</mixed-citation><mixed-citation xml:lang="ru">D. Angelo E., Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010, v. 74, p. 131-139.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Harlow B.L., Weiss N.S., Lofton S. The epidemiology of sarcomas of the uterus. J. Natl. Cancer Inst. 1986, v. 74, p. 399-402.</mixed-citation><mixed-citation xml:lang="ru">Harlow B.L., Weiss N.S., Lofton S. The epidemiology of sarcomas of the uterus. J. Natl. Cancer Inst. 1986, v. 74, p. 399-402.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. El-Khalfaoui K., du BoisA., HeitzF., Kurzeder C., Sehouli J., Harter P. Current and future options in the management and treatment of uterine sarcoma. Ther. Adv. Med. Oncol. 2014, v. 6 (1), p. 21-28.</mixed-citation><mixed-citation xml:lang="ru">El-Khalfaoui K., du BoisA., HeitzF., Kurzeder C., Sehouli J., Harter P. Current and future options in the management and treatment of uterine sarcoma. Ther. Adv. Med. Oncol. 2014, v. 6 (1), p. 21-28.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Amant F., Moerman P., Neven P. et al. Endometrial cancer. Lancet. 2005, v. 74, p. 491-505.</mixed-citation><mixed-citation xml:lang="ru">Amant F., Moerman P., Neven P. et al. Endometrial cancer. Lancet. 2005, v. 74, p. 491-505.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Leibsohn S., d’Ablaing G., Mischell D.R. Jr, Schlaertb J.B. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am. J. Obstet. Gynecol. 1990, v. 162, p. 968-974.</mixed-citation><mixed-citation xml:lang="ru">Leibsohn S., d’Ablaing G., Mischell D.R. Jr, Schlaertb J.B. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am. J. Obstet. Gynecol. 1990, v. 162, p. 968-974.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Sandruck J.L., Escobar P., Lurain J., Fishman D. Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literature.Gyn Oncol 2004 Feb, v. 92:(2) p. 701-704.</mixed-citation><mixed-citation xml:lang="ru">Sandruck J.L., Escobar P., Lurain J., Fishman D. Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literature.Gyn Oncol 2004 Feb, v. 92:(2) p. 701-704.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Harter P., El-Khalfaoui K., Heitz F., A. du Bois. Operative and Conservative Treatment of Uterine Sarcomas. Маrt 2014.</mixed-citation><mixed-citation xml:lang="ru">Harter P., El-Khalfaoui K., Heitz F., A. du Bois. Operative and Conservative Treatment of Uterine Sarcomas. Маrt 2014.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Чекалова М.А. Ультразвуковая диагностика злокачественных новообразований матки. Дисс. д-ра мед. наук. М., 1998, с. 165.</mixed-citation><mixed-citation xml:lang="ru">Чекалова М.А. Ультразвуковая диагностика злокачественных новообразований матки. Дисс. д-ра мед. наук. М., 1998, с. 165.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Major F.J., Blessing J.A. Silverberg S.G. et al. Prognostic factors in early-stage uterine sarcoma. Cancer. 1993, v. 71, p. 1702-1709.</mixed-citation><mixed-citation xml:lang="ru">Major F.J., Blessing J.A. Silverberg S.G. et al. Prognostic factors in early-stage uterine sarcoma. Cancer. 1993, v. 71, p. 1702-1709.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Larson B., Silfversward C., et al. Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981. Acta Oncol. 1990, v. 29, p. 185-191.</mixed-citation><mixed-citation xml:lang="ru">Larson B., Silfversward C., et al. Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981. Acta Oncol. 1990, v. 29, p. 185-191.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Nordal R.R., Kristensen G.B., Kaern J., Stenwig A.E., Pettersen E.O., Trope C.G. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol. 1995, v. 34, p. 797-802.</mixed-citation><mixed-citation xml:lang="ru">Nordal R.R., Kristensen G.B., Kaern J., Stenwig A.E., Pettersen E.O., Trope C.G. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol. 1995, v. 34, p. 797-802.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Pautier P., Genestie C., Rey A., Morice P., Roche B., Lhomme C. et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer (Phila). 2000, v. 88 (6), p. 1425-1431.</mixed-citation><mixed-citation xml:lang="ru">Pautier P., Genestie C., Rey A., Morice P., Roche B., Lhomme C. et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer (Phila). 2000, v. 88 (6), p. 1425-1431.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Лазарева Н.И. Злокачественные мезенхимальные опухоли женских половых органов (клиника, диагностика, лечение, факторы прогноза). Дисс. д-ра мед. наук. М., 2000.</mixed-citation><mixed-citation xml:lang="ru">Лазарева Н.И. Злокачественные мезенхимальные опухоли женских половых органов (клиника, диагностика, лечение, факторы прогноза). Дисс. д-ра мед. наук. М., 2000.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Park J.Y., Park S.K., Kim D.Y. et al. The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcomas of the uterus. Ann Surg Oncol 2011. Nov v. 18 (12): p. 3453-3461.</mixed-citation><mixed-citation xml:lang="ru">Park J.Y., Park S.K., Kim D.Y. et al. The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcomas of the uterus. Ann Surg Oncol 2011. Nov v. 18 (12): p. 3453-3461.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Saiz A.D., Sachdev U., Brodman M.L., Deligdisch L. Metastatic uterine leiomyosarcoma presenting as a primary sarcoma of the parotid gland. Obstet. Gynecol. 1998, v. 92, p. 667-668.</mixed-citation><mixed-citation xml:lang="ru">Saiz A.D., Sachdev U., Brodman M.L., Deligdisch L. Metastatic uterine leiomyosarcoma presenting as a primary sarcoma of the parotid gland. Obstet. Gynecol. 1998, v. 92, p. 667-668.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Leath C.A., Huh W.K., Straughn J.M. Jr., Conner M.G. Uterine leiomyosarcoma metastatic to the thyroid. Obstet. Gynecol. 2002, v. 100, p. 1122-1124.</mixed-citation><mixed-citation xml:lang="ru">Leath C.A., Huh W.K., Straughn J.M. Jr., Conner M.G. Uterine leiomyosarcoma metastatic to the thyroid. Obstet. Gynecol. 2002, v. 100, p. 1122-1124.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Pappa L.L., Zagorianakou N., Kitsiou E., Sintou-Mantela E., Bafa M., Malamnou-Mitsi V. Breast metastasis from uterine leiomyosarcoma diagnosed by fine needle aspiration: a case report. On the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol. Oncol. 2011. Feb 93:(2).</mixed-citation><mixed-citation xml:lang="ru">Pappa L.L., Zagorianakou N., Kitsiou E., Sintou-Mantela E., Bafa M., Malamnou-Mitsi V. Breast metastasis from uterine leiomyosarcoma diagnosed by fine needle aspiration: a case report. On the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol. Oncol. 2011. Feb 93:(2).</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Iwamoto I., Fujino T., Higashi Y., Tsuji T., Nakamura N., KomokataT., DouchiT. Metastasis of uterine leiomyosarcoma to the pancreas. J. Obstet. Gynaecol. Res. 2005, v. 31 (6), p. 531-534.</mixed-citation><mixed-citation xml:lang="ru">Iwamoto I., Fujino T., Higashi Y., Tsuji T., Nakamura N., KomokataT., DouchiT. Metastasis of uterine leiomyosarcoma to the pancreas. J. Obstet. Gynaecol. Res. 2005, v. 31 (6), p. 531-534.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Martin J.L., Boak J.G. Cardiac metastasis from uterine leiomyosarcoma. J. Am. Coll. Cardiol. 1983, v. 2, p. 383-386.</mixed-citation><mixed-citation xml:lang="ru">Martin J.L., Boak J.G. Cardiac metastasis from uterine leiomyosarcoma. J. Am. Coll. Cardiol. 1983, v. 2, p. 383-386.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. O’Brien J.M., Brennan D.D., Taylor D.H., Holloway D.P., Hurson B., O’Keane J.C., Eustace S.J. Skeletal muscle metastasis from uterine leiomyosarcoma. Skeletal. Radiol. 2004, v. 33, p. 655-659.</mixed-citation><mixed-citation xml:lang="ru">O’Brien J.M., Brennan D.D., Taylor D.H., Holloway D.P., Hurson B., O’Keane J.C., Eustace S.J. Skeletal muscle metastasis from uterine leiomyosarcoma. Skeletal. Radiol. 2004, v. 33, p. 655-659.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
